Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering
about
The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherinTargeted therapy for hepatocellular carcinoma: novel agents on the horizonCD44 in cancerSH3P2 is a negative regulator of cell motility whose function is inhibited by ribosomal S6 kinase-mediated phosphorylation.Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapySignaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma.Small GTPases and regulation of cadherin dependent cell-cell adhesion.Synergistic signaling of tumor cell invasiveness by hepatocyte growth factor and hypoxia.MAPK signaling and the kidney.Development of anticancer drugs targeting the MAP kinase pathway.Differential modulation of cadherin-mediated cell-cell adhesion by platelet endothelial cell adhesion molecule-1 isoforms through activation of extracellular regulated kinases.Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in madin-darby canine kidney epithelial cellsRoles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail.Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts.Targeting the ERK signaling pathway in cancer therapy.ERK signaling promotes cell motility by inducing the localization of myosin 1E to lamellipodial tipsEmerging Raf inhibitors.Emerging MEK inhibitors.ERK expression and its correlation with STAT1 in esophageal squamous cell carcinoma.CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.Multiple biological responses are induced by glycosylation-deficient hepatocyte growth factorSuppression of adriamycin-induced apoptosis by sustained activation of the phosphatidylinositol-3'-OH kinase-Akt pathway.Prolonged nuclear retention of activated extracellular signal-regulated kinase 1/2 is required for hepatocyte growth factor-induced cell motility.Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation.Signaling pathways leading to transcription and translation cooperatively regulate the transient increase in expression of c-Fos protein.Differential MAPK pathways utilized for HGF- and EGF-dependent renal epithelial morphogenesis.Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells.Initiation of cell locomotility is a morphogenetic checkpoint in thyroid epithelial cells regulated by ERK and PI3-kinase signals.Downregulation of PTEN expression in psoriatic lesions.Cells set sail after lifting anchor from Myo1E.ERK signalling as a regulator of cell motility.Characterization of a novel RP2-OSTF1 interaction and its implication for actin remodeling.Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met
P2860
Q24298617-B63037A2-8349-4795-8AD7-BCF65235B0E8Q27002288-59650E21-57B2-4F1F-AB4C-BDD074469A6EQ28217782-C9788A1E-24BD-4146-91D8-1241207C9529Q30155580-1F678612-57F4-4D19-882B-37DD50019B2DQ30437740-EA91800C-AA18-4643-84D4-D4E35248AD54Q32134611-CF1EBA53-CF93-4460-84A6-99CBB51E7194Q33850079-5B7D3200-6153-488F-AE00-A084E4194F72Q33946966-F9DA97C6-A7E3-459A-A3E9-E3B2F24C49BCQ34039916-55442561-C68C-42E2-80DF-CF4C10C2610EQ34293560-ED020536-2307-40C3-BCDC-1AFA9FB52890Q34746602-A6202AB7-64F7-47BA-8943-527D6CAFD3F0Q34775192-3D2DC6C1-9C9C-45AD-8A82-EDF83A391830Q34966603-14653B19-9BB3-43C0-B1A4-DBC59163C50BQ34972866-5DC063DC-F50C-4E83-83F8-2497505EEFB2Q35743289-80F2AD37-2A7B-4E09-B05C-72C1A9B6C1F3Q36486780-0BF12FCB-15D4-4372-80E8-195B26C2C422Q37180561-1ACEDBBA-18A0-4668-B980-10986955E83EQ37588717-F8B02DEE-BA60-497D-ABB0-52BDC5AF3503Q37691441-DF39EC39-A40B-4788-8F29-370B179FD0FDQ38826250-BFE00BE3-AB5A-4100-B01F-B93C464A4074Q38946743-2443B7DF-C39D-4A01-845B-FC11CEE90E59Q40461761-289FEC30-AF72-4C13-B1E0-039128DD5D53Q40624347-6FF385D9-C8FD-4287-A377-1FA245F7134CQ40729564-7FBC021B-A6F5-40E4-921C-434FB8F5007FQ40761380-4588E62D-3D6D-4C79-B41F-764CABCD5F7AQ40806188-EE255642-40A5-4B06-A860-75191E5675D9Q40835451-D51A532D-DD82-4B7A-B316-D0E474CA6E68Q42445655-74F75852-2598-43E8-824A-45806CA5F1F6Q43666992-5E694B01-562F-4846-9B06-7C1BBABD69F4Q44801430-436D5C29-A84F-4AC3-A655-4DC8708C15F6Q46097334-3201BD41-4AE1-4187-941C-FB84758B9A2AQ47807637-00349826-CEFF-46D6-BC5F-72946E8E176DQ48183464-FCC082D4-4306-4FCF-99FA-1DC56C8ABAF9Q58324027-C6F6D640-3CC4-4B67-8566-AFDE0ABF2680
P2860
Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Activation of the 41/43 kDa mi ...... factor-induced cell scattering
@ast
Activation of the 41/43 kDa mi ...... factor-induced cell scattering
@en
Activation of the 41/43 kDa mi ...... factor-induced cell scattering
@nl
type
label
Activation of the 41/43 kDa mi ...... factor-induced cell scattering
@ast
Activation of the 41/43 kDa mi ...... factor-induced cell scattering
@en
Activation of the 41/43 kDa mi ...... factor-induced cell scattering
@nl
prefLabel
Activation of the 41/43 kDa mi ...... factor-induced cell scattering
@ast
Activation of the 41/43 kDa mi ...... factor-induced cell scattering
@en
Activation of the 41/43 kDa mi ...... factor-induced cell scattering
@nl
P2093
P3181
P356
P1433
P1476
Activation of the 41/43 kDa mi ...... factor-induced cell scattering
@en
P2093
S Tanimura
S Watanabe
T Nakamura
P2888
P3181
P356
10.1038/SJ.ONC.1201905
P407
P577
1998-07-09T00:00:00Z
P5875
P6179
1022880025